""""""""Myocardial preconditioning is believed to be the state of the art protective technique against ischemic injury. However, Preconditioning has not been applied in conjunction with open heart surgery. The mechanism of preconditioning is also not known. The proposed research will examine the mechanism of preconditioning and attempt to develop preconditioning modalities to salvage arrested heart during open heart surgery. The biochemical pathways activated by the preconditioning phenomenon and the molecular mechanism(s) of the gene expression will be studied. Hearts from the anesthetized rats and rabbits will be excised for isolated perfused heart preparation. To induce ischemic preconditioning, isolated hearts will be made globally ischemic for 5 minutes followed by 10 minutes of reperfusion. The process will be repeated four times. The hearts will then be made ischemic for 30 minutes followed by 60 minutes of reperfusion. To test our hypothesis that preconditioning occurs by tyrosine kinase receptor activation, we will use a tyrosine kinase blocker to inhibit preconditioning. To further explore whether the intracellular signaling occurs through tyrosine kinase-phospholipase D-protein kinase pathway, antiphospholipase D antibody will be used to inhibit phospholipase D activation associated with preconditioning. Activation of protein C kinase and its upstream regulators MAP kinase and MAPKAP kinase will be examined simultaneously. Biopsies and perfusate samples will be used to measure biochemical parameters which will include quantification of phospholipase C and D, diacyl glycerol, phosphatidic acid, protein kinase C, MAP kinase and MAPKAP kinase 2. The cellular injury will be monitored biochemically by measuring the LDH and CK releases. Functionally, both left ventricular systolic and diastolic functional parameters will be continuously monitored on a beat to beat basis. These will include the left ventricular stroke work, elastance, and the time constant of isovolumic relaxation. Induction for the expression of stress-related genes will be studied by Differential Display Technique. The results of this study will not only enable us to understand whether tyrosine kinase-phospholipase D-protein C kinase-MAP kinase-MAPKAP kinase 2 signaling pathway is involved in preconditioning, but also will determine whether preconditioning occurs at the molecular level by reprogramming the gene expression. The results will be useful to develop treatment modalities for preconditioning the heart during open heart surgery.""""""""

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL056803-04
Application #
6351497
Study Section
Surgery and Bioengineering Study Section (SB)
Program Officer
Balshaw, David M
Project Start
1998-02-01
Project End
2003-01-31
Budget Start
2001-02-01
Budget End
2003-01-31
Support Year
4
Fiscal Year
2001
Total Cost
$96,428
Indirect Cost
Name
University of Connecticut
Department
Surgery
Type
Schools of Medicine
DUNS #
City
Farmington
State
CT
Country
United States
Zip Code
06030
Joshi, Mandip; Kotha, Sainath R; Malireddy, Smitha et al. (2014) Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria. Mol Cell Biochem 386:233-49
Thirunavukkarasu, Mahesh; Selvaraju, Vaithinathan; Dunna, Nageswara Rao et al. (2013) Simvastatin treatment inhibits hypoxia inducible factor 1-alpha-(HIF-1alpha)-prolyl-4-hydroxylase 3 (PHD-3) and increases angiogenesis after myocardial infarction in streptozotocin-induced diabetic rat. Int J Cardiol 168:2474-2480
Thirunavukkarasu, Mahesh; Adluri, Ram Sudheer; Juhasz, Bela et al. (2012) Novel role of NADPH oxidase in ischemic myocardium: a study with Nox2 knockout mice. Funct Integr Genomics 12:501-14
Adluri, Ram Sudheer; Thirunavukkarasu, Mahesh; Zhan, Lijun et al. (2011) Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: a study using thioredoxin 1 transgenic mice. J Mol Cell Cardiol 50:239-47
Samuel, Samson Mathews; Thirunavukkarasu, Mahesh; Penumathsa, Suresh Varma et al. (2010) Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats. Circulation 121:1244-55
Samuel, Samson Mathews; Akita, Yuzo; Paul, Debayon et al. (2010) Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats. Diabetes 59:51-60
Penumathsa, Suresh Varma; Maulik, Nilanjana (2009) Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease. Can J Physiol Pharmacol 87:275-86
Vidavalur, Ramesh; Penumathsa, Suresh Varma; Thirunavukkarasu, Mahesh et al. (2009) Sildenafil augments early protective transcriptional changes after ischemia in mouse myocardium. Gene 430:30-7
Koneru, Srikanth; Penumathsa, Suresh V; Thirunavukkarasu, Mahesh et al. (2009) Thioredoxin-1 gene delivery induces heme oxygenase-1 mediated myocardial preservation after chronic infarction in hypertensive rats. Am J Hypertens 22:183-90
Brown, Lindsay; Kroon, Paul A; Das, Dipak K et al. (2009) The biological responses to resveratrol and other polyphenols from alcoholic beverages. Alcohol Clin Exp Res 33:1513-23

Showing the most recent 10 out of 18 publications